How Kayne KYN benefits from the shifts in its industry Technical Weakness 20260506 What faith based investing 701 20260429 ZURA Zura Bio posts far wider Q4 2025 loss than consensus estimates sending its shares down 254 today The edge Revelation Biosciences REVB has in a competitive landscape Risk Aversion 20260508 Micron and SK Hynix Reportedly Join 1 Trillion Market Cap Club on AI Memory Demand Life360 Reports Record Q1 2026 Results With Subscription and Advertising Revenue Surge Pine Labs RVNL Decline After Earnings LIC Campus Activewear See Gains on Strong Triggers Alibaba Unveils Upgraded Zhenwu AI Chip and New Large Language Model Novartis Raises FullYear Sales and Profit Guidance Amid Strong Drug Performance BioMarins BMN 401 Phase 3 Trial Shows Mixed Results in ENPP1 Deficiency BioMarins BMN 401 Phase 3 Trial Shows Mixed Results in ENPP1 Deficiency